Breakthroughs in Solid Tumor Oncology

Seattle, WA US
June 19, 2014 to June 20, 2014

The ever-increasing understanding of the molecular basis of cancer affords astonishing opportunities for early diagnosis, prediction of prognosis, therapies personalized to individual cancer gene profiles and therapies targeted to each individual’s cancer. This two-day symposium will provide a cross-disciplinary review of recently identified and currently utilized targeted therapies for solid tumor malignancies. This symposium’s speakers are leading regional and national experts in the field of oncology and will foster discussion of the most recent advances in cancer care. The diagnosis and treatment of cancer patients is a rapidly evolving area of medicine. Clinicians who treat cancer are increasingly part of a multidisciplinary team that need to understand the most recently discovered and validated targeted therapies. Practitioners should also be conversant with the extraordinary potential and complexities that personalized targeted therapy is bringing to the treatment of cancer.

Target Audience

This educational program is designed to meet the educational needs of oncology-focused clinicians, including general medical oncologists, radiation oncologists, surgeons, physician assistants, nurse practitioners, nurses, pharmacists and other health care providers who manage cancer patients with solid tumors.

Learning Objectives

Following this activity, participants should be able to: 

Keynote Day 1: Precision Medicine in Cancer Care

  • Integrate into practice the extraordinary potential and complexities that personalized targeted therapy brings to cancer therapy
  • Apply the current and near future role of biomarkers and gene profiling for personalization of cancer therapies

Breast Cancer Updates

  • Discuss emerging therapies and new treatment paradigms in breast cancer

GI Cancer Updates

  • Discuss new and emerging therapies in gastrointestinal cancer

Skin Cancer Updates

  • Implement skin cancer immunotherapy treatments into clinical practice more effectively through a sound understanding of how they work

Lung Cancer Updates

  • Discuss new and emerging therapies in lung cancer

Brain Cancer Updates

  • Discuss new and emerging therapies in brain cancer

Keynote Day 2: Exploring Novel Cancer Therapy Targets: Innovative Clinical Trial Design in the Genomic Era

  • Describe innovations in trial design involving genomic profiling
  • Describe pathways for studying and approving innovative new agents (JG)

Bladder and Prostate Cancer Updates

  • Discuss new and emerging therapies in genitourinary cancers

Sarcoma Updates

  • Discuss new and emerging therapies in sarcoma

Survivorship for Oncologists

  • Examine current evidence regarding influence of lifestyle factors on recurrence and survival

GYN Cancer Updates

  • Discuss new and emerging therapies in gynecological cancers
Additional information
Supporters: 

Supported by an educational grant from NOVOCURE and Genentech BioOncology; an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc; and an unrestricted, educational grant from Celgene Corporation

Course summary
Available credit: 
  • 11.75 Participation
  • 11.75 Nurse
  • 11.75 Pharmacist
  • 11.75 Physician
Course opens: 
06/19/2014
Course expires: 
08/22/2014
Event starts: 
06/19/2014 - 8:00am
Event ends: 
06/20/2014 - 3:05pm
Cost:
$0.00
Crowne Plaza Hotel
1113 Sixth Avenue
Seattle, WA 98101
United States

Available Credit

  • 11.75 Participation
  • 11.75 Nurse
  • 11.75 Pharmacist
  • 11.75 Physician

Accreditation Period

Course opens: 
06/19/2014
Course expires: 
08/22/2014

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for certificate viewing/printing